Lykos Therapeutics
Inspiring Change In Mental Healthcare
United States · $150.0M raised
- Business Model
- B2B2C
- Website
- lykospbc.com
- Total Funding
- $150.0M
- Last Round
- $50.0M Series BMay 2025
- Rounds
- 2
About
Lykos Therapeutics develops prescription psychedelics for mental health treatment, focusing on PTSD.
Summary
Lykos Therapeutics is a Biotech company based in United States. It has raised $150.0M in total across 2 rounds, most recently a $50.0M Series B round in May 2025. Investors include Helena, True Ventures and Kittyhawk Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...